A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/23 (2006.01) A61K 9/00 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2755068
Enterally administered calcitonin family members other than amylin, particularly calcitonin itself, are effective to treat Type I diabetes, Type II diabetes or metabolic syndrome, for mitigating insulin resistance, and for reducing serum glucose levels.
L'invention concerne des membres de la famille de la calcitonine administrés entéralement, autres que l'amyline, notamment la calcitonine elle-même, qui sont efficaces pour traiter le diabète de type I, le diabète de type II ou le syndrome métabolique, pour limiter la résistance à l'insuline et pour réduire les niveaux sériques de glucose.
Christiansen Claus
Karsdal Morten Asser
Nordic Bioscience A/s
Sim & Mcburney
LandOfFree
Treatment of diabetes and metabolic syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diabetes and metabolic syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes and metabolic syndrome will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1868333